Amazon Launches AI Shopping Technology for Retailers Signs Kate Spade as First Customer Redwire Corporations Ascent Space Sector Momentum and Contract Wins Drive Investor Interest Micron Shares Surge Toward Best Month Since 1987 Analysts See Value Play Cigna Group CI Downgraded to Hold by Deutsche Bank Citing MultiYear Uncertainty Navitas NVTS Surges 37 as Market Awaits Strategic Business Updates Vestas Wind Systems Shares Decline on Margin Guidance Concerns LXP Q1 2026 Earnings Industrial REIT Posts Wider Loss Than Expected Shares Edge Higher CTVA Q1 2026 Earnings EPS Surges Past Estimates by 254 Shares Edge Higher LEXX Q1 2026 Earnings Loss Narrower Than Expected Stock Jumps 73 Stran Company Inc Q1 2026 Earnings Profitability Achieved Amid Strategic Initiatives ROIV Q1 2026 Earnings EPS Miss as Company Reports Wider Loss BSY Q1 2026 Earnings EPS Surpasses Expectations as Infrastructure Software Demand Remains Solid Flaherty Crumrine Preferred and Income Securities Fund FFC Holds Steady as Markets Digest Shifting Rate Expectations Eagle Point Credit Company ECC Gains Ground as Shares Test Resistance Gaotu Techedu GOTU Surges Over 3 as Shares Approach Key Resistance Level RWTQ Shows Minimal Movement as FixedIncome Market Seeks Direction Wrap Technologies WRAP Edges Higher While Consolidating Near Key Resistance GEF Q1 2026 Earnings EPS Beats Estimates Amid Cautious Market Outlook OXSQG Q1 2026 Earnings EPS Misses Estimates as Investment Income Falls Short Note Price Holds Steady AEON Q4 2025 Earnings EPS Misses Estimates by Wide Margin Amid PreRevenue Stage FIS Q1 2026 Earnings EPS Beats Estimates but Revenue Details Remain Unclear RHP Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Group Demand Wheeler Real Estate Investment Trust Inc 700 Senior Subordinated Convertible Notes Due 2031 WHLRL Q2 2024 Earnings Strong EPS Amid Limited Guidance Box Office Projections For The Mandalorian And Grogu Indicate Potential Disappointment NVST Q1 2026 Earnings EPS Beats Estimates Despite Stock Decline Kymera Therapeutics KYMR Slips Over 2 as Biotech Shares Retreat Support Levels in Focus